Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Dermata Therapeutics, Inc. | SVP, Regulatory Affairs | Stock Option (right to buy) | 25K | Jan 4, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DRMA | Dermata Therapeutics, Inc. | Jan 4, 2024 | 1 | $0 | 4 | Jan 5, 2024 | SVP, Regulatory Affairs |
DRMA | Dermata Therapeutics, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | SVP, Regulatory Affairs |
DRMA | Dermata Therapeutics, Inc. | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Senior Vice President |
DRMA | Dermata Therapeutics, Inc. | Aug 17, 2021 | 12 | $0 | 4 | Aug 17, 2021 | Senior Vice President |
DRMA | Dermata Therapeutics, Inc. | Aug 12, 2021 | 0 | $0 | 3 | Aug 12, 2021 | Senior VP |